NCT06696482View on ClinicalTrials.gov

Effort and Antidepressant Study Test

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Effort Based Decision MakingProsocial BehaviorApathy
Interventions
DRUG

Escitalopram 10mg

Escitalopram 10 mg, encapsulated in an opaque capsule to facilitate blinding of participant and researcher

DRUG

Placebo 10 mg

Placebo 10 mg, encapsulated in an opaque capsule to facilitate blinding of participant and researcher

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

lead

University of Oxford

OTHER

NCT06696482 - Effort and Antidepressant Study Test | Biotech Hunter | Biotech Hunter